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Abstract
We report on two patients presenting with recurrent visual impairment
due to relapsing intracranial Rosai-Dorfman disease. In both patients a
pre-operative diagnosis of meningioma was made. Histological examina-
tion revealed the characteristic picture of S100β and CD68 positive his-
tiocytosis with prominent emperipolesis. In both cases complete tumor
removal by surgery was impossible with residual tissue being the origin of
relapsing disease. Low dose radiation led to partial recovery of vision and
resolution of the intracranial mass. Review of the literature on intracranial
Rosai–Dorfman disease leads us to suggest that postoperative radiother-
apy may be advisable in all cases.
Keywords: Rosai-Dorfman, sinus histiocytosis, multiple meningioma, intracra-
nial neoplasms.
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Introduction: Rosai-Dorfman disease or sinus histiocytosis is a histiocytic
proliferative disorder [24]. Generally patients present in their mid twenties
with cervical lymphadenopathy (87%), frequently preceded by a short non-
specific infection [7]. Extranodal involvement occurs in 25 to 43% [7, 14, 25]
and affects skin (12%), paranasal sinuses (11%), soft tissue (9%), bone (9%),
salivary gland (5%), oral cavity (3%), kidney (2%), lower respiratory tract (2%),
larynx (1%) and rarely other locations [7]. Intracranial lesions are extremely
rare. To our knowledge 32 patients with intracranial masses have been de-
scribed previously [1–5, 8–23, 25–31], including 3 with suprasellar lesions
[2, 20, 31]. Eight patients experienced visual impairment [2, 8, 14, 16, 23,
26, 30, 31], which was the presenting sign in 6 of them [2, 8, 16, 26, 30, 31].
This report follows up the case of Bhattacharjee et al. [2] which was reported
in this journal not having relapsed following surgery. A relapse however oc-
curred after publication and we report the 11-year follow up together with a
second case in which recurrence also occurred.
Case #1: A 78 year old retired Welsh farmer presented at Moorfields Eye
Hospital in June 1989 with progressive bilateral visual impairment. He un-
derwent bifrontal craniotomy with subtotal tumor resection. His condition re-
mained stable until January 1990 [2]. The patient presented however with
further impaired vision in February 1990 and the MRI revealed evidence of
local recurrence of the mass around both optic nerves, which enhanced with
gadolinium on T1 axial brain scans. His visual acuity had declined to 6/24, N24
and 2/13 Ishihara plates on the right; counting fingers at 1 m and only the
Ishihara control plate on the left. In addition to the previous bitemporal hemi-
anopia the left nasal field had decreased to a small “island of vision”. Both
fundi showed loss of nerve fibre layer.
The patient underwent low dose radiotherapy, following which he showed
improvement of his visual acuity to 6/18, 11/17 Ishihara plates on the right;
6/18, 16/17 Ishihara plates on the left. He remained clinically stable for the
following 10 years. He suffered from diabetes mellitus and a transient is-
chaemic attack in 1998. In 1999 he complained of some confusion and blurred
vision. No further investigation was undertaken. He died of unknown cause at
the age of 89.
Case #2: A 47 year old service engineer with rapidly developing right sided
visual loss presented at the National Hospital for Neurology and Neurosurgery
in July 1998. Six weeks previously he had complained of visual impairment and
was found to have visual acuity of 6/24 on the right. Vision had decreased to
light perception only two weeks later. On reflection the patient thought the
loss of vision had begun 2 years previously. On presentation he had left shoul-
der pain, weakness in his right leg, fatigue and frequent headaches starting in
the neck and radiating to the occiput. The medical history reveals a lumbar disc
prolapse two years ago.
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Figure 1: Coronal and axial MRI scans (post gadolinium) of case #2. Image
(A) shows the sellar lesion pre-operative (17.7.1998). Image (B) displays the
post-operative situation with some residual tissue in the region of the optic chi-
asm (18.8.1998). Image (C) demonstrates tumor regrowth 14 months post
OP (09.09.1999). Image (D) is taken 6 months after local low dose radiation
and shows decrease of the sellar mass with some residual tissue.
On examination his visual acuity corrected to 6/6, N12 and 13/13 Ishi-
hara charts correctly identified on the left. No light could be perceived on
the right and there was a right afferent pupillary defect. Loss of nerve fibre
layer was apparent on the right. Apart from a lateralised Weber test to the
right with normal Rinne all other cranial nerves were normal. Sense of smell
was not tested at the time. Sensory examination, tone, power and reflexes
in the lower limbs were normal. No residual deficit from the previous disc
prolaps could be revealed. General examination was normal and there was no
lymphadenopathy.
The CT scan at admission showed multiple mass lesions around the fora-
men magnum, in the chiasmatic cistern arising from the planum sphenoidale,
above the cribriform plate, the right parafalcine region and the cerebello-pontine
angle. These lesions were gadolinium-enhancing on the MRI T1 images and
suggestive of multiple intracranial neoplasms, such as meningioma (figure 1 a).
Chest X ray was normal for heart and lungs, but the left acromion showed
a cystic lesion. No additional skeletal lesions were detected in whole-body
scintigraphy.
The laboratory investigation revealed a decreased level of thyroid stimu-
lating hormone (0.2 mU/L, normal range: 0.25-5.0 mU/L) but normal T3 and
Page 3
JNNP 2001 Rosai–Dorfman disease
T4; increased blood glucose (9.8 mmol/L, normal range: 3.3-9.0 mmol/L) and
increased white cell count of 14.5 G/L with 12.8 G/L neutrophils, 1.2 G/L
lymphocytes, 0.4 G/L monocytes, 0.1 G/L eosinophils. The erythrocyte sedi-
mentation rate was normal (9 mm/h).
He underwent subtotal trans-glabellar resection of the suprasellar mass.
The postoperative visual fields showed a small “island of vision” on the right
and a superiorly-depressed field on the left. His visual acuity corrected to
6/5 on the left and to finger count on the right. The MRI one month after the
operation revealed some residual gadolinium-enhancing tissue around the optic
chiasm (figure 1 b).
One year later the patient complained of recurrence of the visual symp-
toms. His visual acuity worsened to 6/9 on the left and to light perception on
the right. His sense of smell was now impaired. On MRI the sellar mass had
increased in size and extended superiorly, causing bowing of the infundibulum
and tilting the optic chiasm (figure 1 c). The patient underwent radiotherapy
(20 Gy over 10 fractions). Three months later visual acuity had improved to
counting fingers on the right and 6/5 on the left. His visual fields and colour
vision were full on the left. On the right he could perceive hand movements in
all quadrants apart from the lower temporal. At one year follow up the MRI
showed decrease of the sellar mass (figure 1 d). We note that some residual
tissue can still be seen on the axial images.
Figure 2: Histology from case #2: (A) Sheets of histiocytic cells with large
vesicular nuclei, some with nuclear indentations are seen. There is an associ-
ated infiltrate of polymorphs and lymphocytes. Clearly lymphophagocytosis
(emperiopolesis) by the histiocytic cells is seen. (H&E Mag x375)
(B) The histiocytic cells show strong nuclear and cytoplasmatic staining with
S100 protein and lymphophagocytosis is also seen (S100 immunohistochem-
istry Mag x625).
Histology: The histology of case #1 has been discussed in detail by Bhat-
tacharjee et al. and has been reviewed by one co-author (MT) and is identical
to case #2.
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Case #2: histology of the suprasellar dural mass (30x20x8 mm) showed
collagenous tissue with mixed chronic inflammatory cells and numerous poly-
morphs with very occasional eosinophils. Interspersed within this infiltrate
were large cells with vesicular nuclei, some with indented nuclear membranes,
and abundant cytoplasm. Prominent emperipolesis and phagocytosis of neu-
trophils and red blood cells by these cells was noted. Immunohistochemistry
with positive labeling for S100b and CD68 (PKM1) and negative staining for
CD1a confirmed the histiocytic cell lineage (figure 2).
Discussion: Rosai-Dorfman disease or “sinus histiocytosis with massive lym-
phadenopathy”was initially described in the French literature as a lipid storage
disorder (adtes avec surcharge lipidique) possibly developing after inflamma-
tion. To our knowledge the first published case was a 24 year old male from
Guadeloupe, biopsied in 1959 [6]. In 1969 Rosai and Dorfman summarized
the triad of massive cervical lymphadenopathy, expanded lymph node sinuses
and characteristic histiocytes showing emperipolesis as a new and distinct en-
tity among the histiocytosis [24]. Emperiopolesis (lymphocytophagocytosis)
describes the presence of lymphocytes within the histiocytes. Because of the
occurrence of extranodal disease in about 43% of patients the term “Rosai-
Dorfman disease” is widely used in the literature for this subgroup [7].
An over-representation of patients with extranodal disease is likely as pub-
lication of rare cases dominates the literature. CNS involvement remains how-
ever rare with 32 reported cases [1–5, 8–23, 25–31]. There is a male pre-
dominance of 65.6% (21 males, 11 females). The mean age is with 37 years
(range 2-78 years, SD 19) slightly higher than the 20.6 years (SD 20.5) re-
ported by Rosai and Dorfman for the entire entity [8]. Neurological symptoms
preceded the diagnosis by a mean of 3 years. Focal neurological signs, seizures
or headache are the most frequent presenting symptoms.
In general the natural history of nodular sinus histiocytosis has been re-
ported benign with spontaneous remission. If however the location of the
tumor involves the brain or spinal cord relapsing disease becomes a serious
problem.
Intracranial tumor regrowth or recurrence of symptoms has been reported
in 14% (4[3, 21, 30] out of 29[1, 3–5, 8–23, 25–31]) patients excluding our
case #1 [2] and two patients who died[8, 28]. The mean follow up for these
patients was 10.1 years (median 5, range 0.5-30 years). Relapsing patients
tend to be slightly older (mean 42 years) without remarkable gender prefer-
ence (2 male, 2 female). In further 25% of patients with CNS involvement no
follow up information could be obtained from the literature [8, 9, 17, 20, 22,
26]. We note that the mean follow up in patients reported as “stable” was
1.5 years (median 1 year, range 1 month - 2 years) [1, 4, 5, 11, 12, 14–16,
18, 19, 23, 25, 27–29]. But only in 52% of these patients brain imaging has
been performed at follow up [5, 14, 18, 19, 23, 25, 27, 29].
From the surviving 30 patients (17 stable, 4 relapsing, 8 no follow up
information available) 18 had no follow up brain imaging at all, 5 had CT [2,
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3, 5, 18] and 7 had MRI [14, 19, 23, 25, 27, 29, 31]. Seventy percent of
“stable” patients were male (11 male, 5 female). Two patients died. One
directly related to disease (55 years, female) [8] and the other one (54 years,
female) due to intracerebral hemorrhage following craniotomy [30].
Surgery was performed in 93%with the preoperative diagnosis being menin-
gioma. One patient underwent laminectomy for a spinal mass lesion extending
from C1-C6 [8]. In one patient transphenoidal biopsy established the diagno-
sis of intracerebral Rosai-Dorfman disease and radiation (1000 cGy in 200 cGy
daily) lead to tumor resolution at 2 months follow up [27]. Three patients with
spinal involvement (Foucar’s case #1, #4 and #8) received radiation. Case #1
and #8 also had laminectomy and case #8 steroids. Case #1 and #8 improved
with treatment. Patient #4 died 10 years later due to intracranial involvement
[8]. Another case of subtotal surgery with additional radiation (1500 rads)
and no relapse at 14 months follow up is reported by Trudel et al. [28].
In summary it seems advisable to ensure a 5 year follow up period (me-
dian relapse time) including brain imaging in patients with intracranial Rosai-
Dorfman disease. The main pre-operative diagnosis remains meningioma, but
histology should establish the diagnosis. In cases with subtotal tumor resec-
tion or recurrence of neurological symptoms we would treat with local low
dose radiation rather early than late.
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